AtM B cells exhibit an exhausted phenotype and are increased in non-small cell lung cancer (NSCLC) and mesothelioma patients with non-response to ICB therapy, suggesting that AtM B cells may impede the ICB treatment response 72. Here, ATM is linked to non-small cell lung carcinoma.